| Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities CM Gay, CA Stewart, EM Park, L Diao, SM Groves, S Heeke, BY Nabet, ... Cancer cell 39 (3), 346-360. e7, 2021 | 511 | 2021 |
| Nrf2 and Keap1 abnormalities in non–small cell lung carcinoma and association with clinicopathologic features LM Solis, C Behrens, W Dong, M Suraokar, NC Ozburn, CA Moran, ... Clinical cancer research 16 (14), 3743-3753, 2010 | 502 | 2010 |
| Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial T Cascone, WN William Jr, A Weissferdt, CH Leung, HY Lin, A Pataer, ... Nature medicine 27 (3), 504-514, 2021 | 436 | 2021 |
| Mechanical regulation of glycolysis via cytoskeleton architecture JS Park, CJ Burckhardt, R Lazcano, LM Solis, T Isogai, L Li, CS Chen, ... Nature 578 (7796), 621-626, 2020 | 383 | 2020 |
| Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion DH Peng, BL Rodriguez, L Diao, L Chen, J Wang, LA Byers, Y Wei, ... Nature communications 11 (1), 4520, 2020 | 240 | 2020 |
| Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment X Zhu, Y Xu, LM Solis, W Tao, L Wang, C Behrens, X Xu, L Zhao, D Liu, ... Proceedings of the National Academy of Sciences 112 (25), 7779-7784, 2015 | 193 | 2015 |
| CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma P Saintigny, E Massarelli, S Lin, YH Ahn, Y Chen, S Goswami, B Erez, ... Cancer research 73 (2), 571-582, 2013 | 181 | 2013 |
| Ets2 mediated tumor suppressive function and met oncogene inhibition in human non–small cell lung cancer M Kabbout, MM Garcia, J Fujimoto, DD Liu, D Woods, CW Chow, ... Clinical cancer research 19 (13), 3383-3395, 2013 | 165 | 2013 |
| Robust gene expression signature from formalin-fixed paraffin-embedded samples predicts prognosis of non–small-cell lung cancer patients Y Xie, G Xiao, KR Coombes, C Behrens, LM Solis, G Raso, L Girard, ... Clinical cancer research 17 (17), 5705-5714, 2011 | 164 | 2011 |
| ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion W Long, CE Foulds, J Qin, J Liu, C Ding, DM Lonard, LM Solis, II Wistuba, ... The Journal of clinical investigation 122 (5), 1869-1880, 2012 | 161 | 2012 |
| EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non–small cell lung carcinoma C Behrens, LM Solis, H Lin, P Yuan, X Tang, H Kadara, E Riquelme, ... Clinical cancer research 19 (23), 6556-6565, 2013 | 154 | 2013 |
| Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung P Yuan, H Kadara, C Behrens, X Tang, D Woods, LM Solis, J Huang, ... PloS one 5 (2), e9112, 2010 | 144 | 2010 |
| Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity Y Hailemichael, DH Johnson, N Abdel-Wahab, WC Foo, SE Bentebibel, ... Cancer Cell 40 (5), 509-523. e6, 2022 | 134 | 2022 |
| Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome LM Solis, C Behrens, MG Raso, HY Lin, H Kadara, P Yuan, H Galindo, ... Cancer 118 (11), 2889-2899, 2012 | 128 | 2012 |
| TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer D Ai, J Yao, F Yang, L Huo, H Chen, W Lu, LMS Soto, M Jiang, MG Raso, ... Modern Pathology 34 (4), 710-719, 2021 | 115 | 2021 |
| STING pathway expression identifies NSCLC with an immune-responsive phenotype CM Della Corte, T Sen, CM Gay, K Ramkumar, L Diao, RJ Cardnell, ... Journal of Thoracic Oncology 15 (5), 777-791, 2020 | 108 | 2020 |
| Identification of Gene Signatures and Molecular Markers for Human Lung Cancer Prognosis using an In vitro Lung Carcinogenesis System H Kadara, L Lacroix, C Behrens, L Solis, X Gu, JJ Lee, E Tahara, D Lotan, ... Cancer Prevention Research 2 (8), 702-711, 2009 | 101 | 2009 |
| Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features H Dejima, X Hu, R Chen, J Zhang, J Fujimoto, ER Parra, C Haymaker, ... Nature communications 12 (1), 2722, 2021 | 85 | 2021 |
| Human papillomavirus and Epstein-Barr virus infections in breast cancer from chile F Aguayo, N Khan, C Koriyama, C González, S Ampuero, O Padilla, ... Infectious agents and cancer 6, 1-7, 2011 | 85 | 2011 |
| Promoter hypermethylation of BRCA1 correlates with absence of expression in hereditary breast cancer tumors T Tapia, SV Smalley, P Kohen, A Muñoz, LM Solis, A Corvalan, ... Epigenetics 3 (3), 157-163, 2008 | 85 | 2008 |
